PAUL GARSON: Open Payments
NPI 1124034392 · SOUTHAMPTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 8 payments from 6 companies in 2025. Trend: 2023 $32 · 2024 $165 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 3 | $85 |
| Travere Therapeutics, Inc. | 1 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Amneal Pharmaceuticals LLC | 1 | $28 |
Products named: VYEPTI, Kerendia, JYNARQUE, INGREZZA, CREXONT.
Industry payments across NY — which companies pay providers there.
